The
glutathione (GSH)-dependent
antioxidant system has been demonstrated to inhibit
atherosclerosis. Macrophage CD36 uptakes
oxidized low density lipoprotein (
oxLDL) thereby facilitating foam cell formation and development of
atherosclerosis. It remains unknown if GSH can influence macrophage CD36 expression and cellular
oxLDL uptake directly. Herein we report that treatment of macrophages with l-
buthionine-S,R-sulfoximine (BSO) decreased cellular GSH production and ratios of GSH to
glutathione disulfide (GSH/
GSSG) while increasing production of
reactive oxygen species. Associated with decreased GSH levels, macrophage CD36 expression was increased, which resulted in enhanced cellular
oxLDL uptake. In contrast, N-acetyl
cysteine and
antioxidant enzyme (
catalase or
superoxide dismutase) blocked BSO-induced CD36 expression as well as
oxLDL uptake. In vivo, administration of mice with BSO increased CD36 expression in peritoneal macrophages and kidneys. BSO had no effect on CD36
mRNA expression and promoter activity but still induced
CD36 protein expression in macrophages lacking
peroxisome proliferator-activated receptor γ expression, suggesting it induced CD36 expression at the translational level. Indeed, we determined that BSO enhanced CD36 translational efficiency. Taken together, our study demonstrates that cellular GSH levels and GSH/
GSSG status can regulate macrophage CD36 expression and cellular
oxLDL uptake and demonstrate an important anti-atherogenic function of the GSH-dependent
antioxidant system by providing a novel molecular mechanism.